{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:22:23Z","timestamp":1790655743005,"version":"4.1.0"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Diffuse intrinsic pontine glioma (DIPG), recently reclassified as a subtype of diffuse midline glioma, is a highly aggressive brainstem tumor affecting children and young adults, with no cure and a median survival of only 9 months. Conventional treatments are ineffective, highlighting the need for alternative therapeutic strategies such as cellular immunotherapy. However, identifying unique and tumor-specific cell surface antigens to target with chimeric antigen receptor (CAR) or T-cell receptor (TCR) therapies is challenging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, a multi-omics approach was used to interrogate patient-derived DIPG cell lines and to identify potential targets for immunotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Through immunopeptidomics, a range of targetable peptide antigens from cancer testis and tumor-associated antigens as well as peptides derived from human endogenous retroviral elements were identified. Proteomics analysis also revealed upregulation of potential drug targets and cell surface proteins such as Cluster of differentiation 27 (CD276) B7 homolog 3 protein (B7H3), Interleukin 13 alpha receptor 2 (IL-13R\u03b12), Human Epidermal Growth Factor Receptor 3 (HER2), Ephrin Type-A Receptor 2 (EphA2), and Ephrin Type-A Receptor 3 (EphA3).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The results of this study provide a valuable resource for the scientific community to accelerate immunotherapeutic approaches for DIPG. Identifying potential targets for CAR and TCR therapies could open up new avenues for treating this devastating disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2023.1192448","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T13:51:43Z","timestamp":1691761903000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma"],"prefix":"10.3389","volume":"13","author":[{"given":"Kirti","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacie S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"Mifsud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouya","family":"Faridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew I.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarrod J.","family":"Sandow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Monje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri H.","family":"Ramarathinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misty R.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony W.","family":"Purcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta neuropathologica"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.5114\/wo.2014.40559","article-title":"Glioblastoma multiforme - an overview","volume":"18","author":"Urbanska","year":"2014","journal-title":"Contemp Oncol (Poznan Poland)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox107","article-title":"Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study","volume":"19","author":"Cooney","year":"2017","journal-title":"Neuro-oncology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1101657108","article-title":"Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma","volume":"108","author":"Monje","year":"2011","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B6","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.molcel.2019.08.030","article-title":"Histone variant and cell context determine H3K27M reprogramming of the enhancer landscape and oncogenic state","volume":"76","author":"Nagaraja","year":"2019","journal-title":"Mol Cell"},{"key":"B7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ccell.2017.03.011","article-title":"Transcriptional dependencies in diffuse intrinsic pontine glioma","volume":"31","author":"Nagaraja","year":"2017","journal-title":"Cancer Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao4750","article-title":"Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq","volume":"360","author":"Filbin","year":"2018","journal-title":"Sci (New York NY)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01205-w","article-title":"K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas","volume":"54","author":"Jessa","year":"2022","journal-title":"Nat Genet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01236-3","article-title":"The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location","volume":"54","author":"Liu","year":"2022","journal-title":"Nat Genet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta neuropathologica"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat Genet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3340\/jkns.2018.0008","article-title":"Diffuse intrinsic pontine glioma : clinical features, molecular genetics, and novel targeted therapeutics","volume":"61","author":"Mathew","year":"2018","journal-title":"J Korean Neurosurgical Soc"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/jpn.JPN_85_20","article-title":"Remission of pediatric diffuse intrinsic pontine glioma: case report and review of the literature","volume":"16","author":"Espirito Santo","year":"2021","journal-title":"J Pediatr Neurosci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.03.014","article-title":"On the dependency of cellular protein levels on mRNA abundance","volume":"165","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0006-x","article-title":"Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas","volume":"24","author":"Mount","year":"2018","journal-title":"Nat Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04489-4","article-title":"GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas","volume":"603","author":"Majzner","year":"2022","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa249","article-title":"Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-na\u00efve diffuse midline glioma models","volume":"23","author":"Vitanza","year":"2021","journal-title":"Neuro-oncology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-22-0750","article-title":"Intraventricular B7-H3 CAR T cells for diffuse intrinsic pontine glioma: preliminary first-in-human bioactivity and safety","volume":"13","author":"Vitanza","year":"2022","journal-title":"Cancer Discovery"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.718030","article-title":"T-cell immunotherapy for pediatric high-grade gliomas: new insights to overcoming therapeutic challenges","volume":"11","author":"Haydar","year":"2021","journal-title":"Front Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa3828","article-title":"Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells","volume":"348","author":"Carreno","year":"2015","journal-title":"Sci (New York NY)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2103485","article-title":"Overall survival benefit with tebentafusp in metastatic uveal melanoma","volume":"385","author":"Nathan","year":"2021","journal-title":"New Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2119662","article-title":"Neoantigen T-cell receptor gene therapy in pancreatic cancer","volume":"386","author":"Leidner","year":"2022","journal-title":"New Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.8.4.421","article-title":"Therapeutic human papillomavirus vaccines: current clinical trials and future directions","volume":"8","author":"Hung","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"B27","doi-asserted-by":"publisher","first-page":"5660","DOI":"10.1038\/s41467-020-19464-8","article-title":"Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers","volume":"11","author":"Saini","year":"2020","journal-title":"Nat Commun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI121476","article-title":"Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma","volume":"128","author":"Smith","year":"2019","journal-title":"J Clin Invest"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1836-9","article-title":"The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy","volume":"135","author":"Neidert","year":"2018","journal-title":"Acta neuropathologica"},{"key":"B30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41392-020-00448-5","article-title":"Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer","volume":"6","author":"Ding","year":"2021","journal-title":"Signal transduction targeted Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.818679","article-title":"Phase 1 clinical trial evaluating the safety and anti-tumor activity of ADP-A2M10 SPEAR T-cells in patients with MAGE-A10+ Head and neck, melanoma, or urothelial tumors","volume":"12","author":"Hong","year":"2022","journal-title":"Front Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1172\/jci140378","article-title":"Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma","volume":"130","author":"Mueller","year":"2020","journal-title":"J Clin Invest"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa4967","article-title":"Adoptive cell transfer as personalized immunotherapy for human cancer","volume":"348","author":"Rosenberg","year":"2015","journal-title":"Sci (New York NY)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1002\/cpz1.92","article-title":"Isolation of HLA bound peptides by immunoaffinity capture and identification by mass spectrometry","volume":"1","author":"Pandey","year":"2021","journal-title":"Curr Protoc"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/0198-8859(81)90065-3","article-title":"Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28","volume":"3","author":"Parham","year":"1981","journal-title":"Hum Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)86749-2","article-title":"Purification of immunologically active HLA-A and -B antigens by a series of monoclonal antibody columns","volume":"254","author":"Parham","year":"1979","journal-title":"J Biol Chem"},{"key":"B37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molimm.2020.04.008","article-title":"In-depth mining of the immunopeptidome of an acute myeloid leukemia cell line using complementary ligand enrichment and data acquisition strategies","volume":"123","author":"Pandey","year":"2020","journal-title":"Mol Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1089\/hyb.1.1982.1.87","article-title":"Monoclonal antibody to HLA-A3","volume":"1","author":"Berger","year":"1982","journal-title":"Hybridoma"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201100463","article-title":"Using iRT, a norMalized retention time for more targeted measurement of peptides","volume":"12","author":"Escher","year":"2012","journal-title":"Proteomics"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M111.010587","article-title":"PEAKS DB: de novo sequencing assisted database search for sensitive and accurate peptide identification","volume":"11","author":"Zhang","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth1109-786","article-title":"Improved visualization of protein consensus sequences by iceLogo","volume":"6","author":"Colaert","year":"2009","journal-title":"Nat Methods"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data","volume":"199","author":"Jurtz","year":"2017","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1006","article-title":"The immune epitope database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Sci (New York NY)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2016.136","article-title":"The MaxQuant computational platform for mass spectrometry-based shotgun proteomics","volume":"11","author":"Tyanova","year":"2016","journal-title":"Nat Protoc"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M113.031591","article-title":"Accurate proteome-wide label-free quantification by delayed norMalization and maximal peptide ratio extraction, termed MaxLFQ","volume":"13","author":"Cox","year":"2014","journal-title":"Mol Cell Proteomics MCP"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2021.10.020","article-title":"ggVolcanoR: A Shiny app for customizable visualization of differential expression datasets","volume":"19","author":"Mullan","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121314","article-title":"A mass spectrometric-derived cell surface protein atlas","volume":"10","author":"Bausch-Fluck","year":"2015","journal-title":"PloS One"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinf (Oxford England)"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.202000244","article-title":"Proteomic analyses reveal that immune integrins are major targets for regulation by Membrane-Associated Ring-CH (MARCH) proteins MARCH2, 3, 4 and 9","volume":"21","author":"Sandow","year":"2021","journal-title":"Proteomics"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.2000.4315","article-title":"Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes","volume":"305","author":"Krogh","year":"2001","journal-title":"J Mol Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.2000.4315","article-title":"A hidden Markov model for predicting transmembrane helices in protein sequences","volume":"6","author":"Sonnhammer","year":"1998","journal-title":"Proc Int Conf Intelligent Syst Mol Biol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(82)90137-5","article-title":"Monoclonal antibodies: Purification, fragmentation and application to structural and functional studies of class I MHC antigens","volume":"53","author":"Parham","year":"1982","journal-title":"J Immunol Methods"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-019-0133-y","article-title":"Mass spectrometry\u2013based identification of MHC-bound peptides for immunopeptidomics","author":"Purcell","year":"2019","journal-title":"Nat Protoc"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws042","article-title":"Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy","volume":"135","author":"Dutoit","year":"2012","journal-title":"Brain J Neurol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj3671","article-title":"Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy","volume":"8","author":"Bonaventura","year":"2022","journal-title":"Sci Adv"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-017-1978-y","article-title":"TANTIGEN: a comprehensive database of tumor T cell antigens","volume":"66","author":"Olsen","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn673","article-title":"CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens","volume":"37","author":"Almeida","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxg074","article-title":"Naturally occurring peptides associated with HLA-A2 in ovarian cancer cell lines identified by mass spectrometry are targets of HLA-A2-restricted cytotoxic T cells","volume":"15","author":"Ramakrishna","year":"2003","journal-title":"Int Immunol"},{"key":"B61","article-title":"Integrated functional genomics approach for the design of patient-individual antitumor vaccines","volume":"62","author":"Weinschenk","year":"2002","journal-title":"Cancer Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-008-0655-6","article-title":"HLA ligand profiles of primary renal cell carcinoma maintained in metastases","volume":"58","author":"Stickel","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193565","article-title":"IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma","volume":"13","author":"Berlow","year":"2018","journal-title":"PloS One"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1610497","article-title":"Regression of glioblastoma after chimeric antigen receptor T-cell therapy","volume":"375","author":"Brown","year":"2016","journal-title":"New Engl J Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.3390\/cancers13184525","article-title":"The translocator protein (TSPO) genetic polymorphism A147T is associated with worse survival in male glioblastoma patients","volume":"13","author":"Troike","year":"2021","journal-title":"Cancers"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s40336-016-0168-9","article-title":"TSPO expression in brain tumours: is TSPO a target for brain tumour imaging","volume":"4","author":"Roncaroli","year":"2016","journal-title":"Clin Trans Imaging"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.154179","article-title":"High FN1 expression correlates with gastric cancer progression","volume":"239","author":"Li","year":"2022","journal-title":"Pathol - Res Pract"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.913659","article-title":"FN1 overexpression is correlated with unfavorable prognosis and immune infiltrates in breast cancer","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Genet"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6051092","article-title":"BCHE as a prognostic biomarker in endometrial cancer and its correlation with immunity","volume":"2022","author":"Liu","year":"2022","journal-title":"J Immunol Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0821-8","article-title":"Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid\/rhabdoid tumors","volume":"26","author":"Theruvath","year":"2020","journal-title":"Nat Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf2968","article-title":"Disrupting the CD47-SIRP\u03b1 anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for Malignant pediatric brain tumors","author":"Gholamin","year":"2017","journal-title":"Sci Trans Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13045-021-01197-w","article-title":"Targeting CD47 for cancer immunotherapy","volume":"14","author":"Jiang","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7601281","article-title":"Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein","volume":"25","author":"Jung","year":"2006","journal-title":"EMBO J"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/nature24014","article-title":"Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma","volume":"549","author":"Venkatesh","year":"2017","journal-title":"Nature"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2936","article-title":"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations","volume":"46","author":"Buczkowicz","year":"2014","journal-title":"Nat Genet"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/nm0715-827a","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-013-1218-2","article-title":"Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes","volume":"127","author":"Saratsis","year":"2014","journal-title":"Acta neuropathologica"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos067","article-title":"Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid","volume":"14","author":"Saratsis","year":"2012","journal-title":"Neuro-oncology"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.233","article-title":"Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy","volume":"29","author":"Berlin","year":"2015","journal-title":"Leukemia"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2883","article-title":"Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival","volume":"18","author":"Walter","year":"2012","journal-title":"Nat Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz1029","article-title":"Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools","volume":"48","author":"Gonzalez-Galarza","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-012-0973-6","article-title":"Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment","volume":"110","author":"Hashizume","year":"2012","journal-title":"J neuro-oncol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5657","article-title":"Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma","volume":"6","author":"Spel","year":"2015","journal-title":"Oncotarget"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070522","article-title":"Increased PRAME-specific CTL killing of acute myeloid leukemia cells by either a novel histone deacetylase inhibitor chidamide alone or combined treatment with decitabine","volume":"8","author":"Yao","year":"2013","journal-title":"PloS One"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208395","article-title":"GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion","volume":"24","author":"Shashidhar","year":"2005","journal-title":"Oncogene"},{"key":"B86","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","article-title":"Integrins in cancer: biological implications and therapeutic opportunities","volume":"10","author":"Desgrosellier","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"B87","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3390\/ijms21030888","article-title":"Integrin signaling in glioma pathogenesis: from biology to therapy","volume":"21","author":"Ellert-Miklaszewska","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B88","doi-asserted-by":"publisher","first-page":"20276","DOI":"10.1038\/s41598-019-56696-1","article-title":"IL-33\/ST2 axis promotes glioblastoma cell invasion by accumulating tenascin-C","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci Rep"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00092","article-title":"Invaders exposed: understanding and targeting tumor cell invasion in diffuse intrinsic pontine glioma","volume":"10","author":"Kluiver","year":"2020","journal-title":"Front Oncol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.phrs.2016.08.004","article-title":"Integrins in glioblastoma: Still an attractive target","volume":"113","author":"Paolillo","year":"2016","journal-title":"Pharmacol Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003816","article-title":"Targeting of the alpha(v) beta(3) integrin complex by CAR-T cells leads to rapid regression of diffuse intrinsic pontine glioma and glioblastoma","volume":"10","author":"Cobb","year":"2022","journal-title":"J immunother Cancer"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-018-0018-1","article-title":"Recombinant viruses with other anti-cancer therapeutics: a step towards advancement of oncolytic virotherapy","volume":"25","author":"Lal","year":"2018","journal-title":"Cancer Gene Ther"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1038\/s41467-019-10043-0","article-title":"The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models","volume":"10","author":"Mart\u00ednez-V\u00e9lez","year":"2019","journal-title":"Nat Commun"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00546","article-title":"Histone deacetylase inhibitors in pediatric brain cancers: biological activities and therapeutic potential","volume":"8","author":"Perla","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3855","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-021-04313-2","article-title":"Panobinostat penetrates the blood-brain barrier and achieves effective brain concentrations in a murine model","volume":"88","author":"HOman","year":"2021","journal-title":"Cancer chemother Pharmacol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1044248","article-title":"Anticholinesterase activity of Areca Catechu: In Vitro and in silico green synthesis approach in search for therapeutic agents against Alzheimer's disease","volume":"13","author":"Pradeep","year":"2022","journal-title":"Front Pharmacol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ejca.2022.04.028","article-title":"Target actionability review to evaluate CDK4\/6 as a therapeutic target in paediatric solid and brain tumours","volume":"170","author":"Schubert","year":"2022","journal-title":"Eur J Cancer (Oxford Engl 1990)"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28879","article-title":"A phase I trial of the CDK 4\/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042)","volume":"68","author":"Van Mater","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.3390\/cancers12102973","article-title":"The role of translocator protein TSPO in hallmarks of glioblastoma","volume":"12","author":"Ammer","year":"2020","journal-title":"Cancers"},{"key":"B101","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ebiom.2019.08.030","article-title":"B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres","volume":"47","author":"Nehama","year":"2019","journal-title":"EBioMedicine"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-18-0432","article-title":"CAR T cells targeting B7-H3, a pan-cancer antigen, demonstrate potent preclinical activity against pediatric solid tumors and brain tumors","volume":"25","author":"Majzner","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B103","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41392-021-00505-7","article-title":"Administration of B7-H3 targeted chimeric antigen receptor-T cells induce regression of glioblastoma","volume":"6","author":"Tang","year":"2021","journal-title":"Signal transduction targeted Ther"},{"key":"B104","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3390\/genes9030159","article-title":"CD99: A cell surface protein with an oncojanus role in tumors","volume":"9","author":"Manara","year":"2018","journal-title":"Genes"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1177\/1947601912473603","article-title":"Overexpression of CD99 increases the migration and invasiveness of human Malignant glioma cells","volume":"3","author":"Seol","year":"2012","journal-title":"Genes Cancer"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1192448\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T13:51:58Z","timestamp":1691761918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1192448\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":106,"alternative-id":["10.3389\/fonc.2023.1192448"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1192448","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"article-number":"1192448"}}